Related Experiment Videos
Childhood mefloquine-induced mania and psychosis: a case report
1Department of Pediatrics, The Institute of Child Health, Kolkata, West Bengal, India. rajoothapa@yahoo.co.in
Abstract:
Mefloquine, a commonly used oral antimalarial is occasionally associated with severe, neuropsychiatric adverse effects, especially in adults. Such events are extremely rare in children. The authors report on an 11-year-old, otherwise healthy girl from Eastern India, a malaria-endemic region, who developed mania and psychosis following intake of a therapeutic dose of mefloquine for Plasmodium falciparum malaria. She recovered satisfactorily with risperidone therapy. To our knowledge, there is only one documented instance of mefloquine-induced psychosis in the pediatric literature to date. Those caring for children need to realize that severe neuropsychiatric manifestations may be seen in the pediatric age group. A positive history of intake of the offending drug with careful exclusion of other etiologies usually clinches the diagnosis.
Insights
Mefloquine (an antimalarial drug) can cause severe neuropsychiatric effects, even in children. This case highlights a rare instance of psychosis in an 11-year-old girl, emphasizing the need for awareness in pediatric care.
Area of Science:
- Pharmacology
- Neuroscience
- Tropical Medicine
Background:
- Mefloquine is a widely prescribed oral antimalarial medication.
- Neuropsychiatric adverse effects are known but considered rare in children.
- Plasmodium falciparum malaria is prevalent in Eastern India.
Observation:
- An 11-year-old girl in Eastern India developed mania and psychosis.
- These symptoms occurred after receiving a standard therapeutic dose of mefloquine.
- The patient was otherwise healthy prior to this event.
Findings:
- This case represents a rare instance of mefloquine-induced psychosis in a pediatric patient.
- Diagnosis was established by linking drug intake to symptoms and excluding other causes.
- The patient's symptoms resolved with risperidone treatment.
Implications:
- Healthcare providers should be vigilant for severe neuropsychiatric reactions to mefloquine in children.
- This case underscores the potential for serious adverse events in the pediatric population.
- Awareness and careful patient history are crucial for diagnosing drug-induced neuropsychiatric disorders.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Malaria
Rocky Mountain Spotted Fever
Bipolar Disorder
Psychosis and Antipsychotic Drugs: Overview